Arizona researchers are playing a key role in the search for new ways to identify CTE before death. In a study released online in the New England Journal of Medicine, a cross-national team, including local researchers from Arizona State University, Banner Alzheimer’s Institute, the Mayo Clinic College of Medicine, and Boston University have brought us a step closer to diagnosing CTE in living, former NFL players.Continue reading→

Washington, D.C. (April 3, 2019) – Senator Kyrsten Sinema was recognized today by the Biotechnology Innovation Organization (BIO) for her leadership as an Innovator in Biotechnology. Senator Sinema received the award in conjunction with today’s BIO Legislative Day Fly-In.Continue reading→

While antibiotic resistance is on the rise, pharmaceutical companies are making fewer and fewer new antibiotics. UA immunobiologist Michael Johnson says this trend is in urgent need of reversal and believes copper might just be the key.Continue reading→

The Flinn Foundation and The Arizona Republic have entered into a grant-based partnership that will enable the state’s largest media platform to pursue a multimedia initiative to deepen public understanding of the biosciences in Arizona, including research, industry development, and clinical advances.Continue reading→

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and Europe. Continue reading→

Continue reading→

Get the information and watch the video to learn more about vaccines, symptoms, and who is at riskContinue reading→

Grant allows for development of new online platform which will be a cell phone app for pregnant women and new moms struggling with opioid addiction is helping them get to doctor appointments on time, chat online with counselors, message their physician and watch videos that teach them about changing their behavior.Continue reading→

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief for the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has been selected to receive the 2019 Distinguished Public Service Award from the American Association for Cancer Research (AACR). The AACR is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer.Continue reading→